Mahmoud ElSohly (Presenter)
University of Mississippi
Bio: Dr. Mahmoud A. ElSohly is a Research Professor at The National Center for Natural Products Research, and Professor of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi and is the Director of the NIDA Marijuana Project. He is also the President and Laboratory Director of ElSohly Laboratories Incorporated, an analytical forensic drug testing and a product development laboratory. He received his undergraduate and Masters from Cairo University, Cairo, Egypt and his Ph.D. from the University of Pittsburgh, School of Pharmacy, Pittsburgh, PA. He has over 40 years’ experience working with the isolation of natural products, synthetic, analytical and forensic chemistry. He has more than 30 patents and approximately 300 publications in these areas of science. He has been working on cannabis and cannabinoids for >40 years with an extensive list of publications.
Authorship: Mahmoud A. ElSohly
National Center for Natural Products Research, The Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi
| Short Abstract Cannabis is an annual, dioceous (occasionally monoecious) and wind pollinated plant. The plant has been reported to contain >500 different compounds, of which 120 are the cannabinoids. Delta-9-tetrahydrocannabinol (Delta-9-THC), the major biologically active compound and cannabidiol (CBD), a non-psychoactive cannabinoid are the most studied cannabinoids for various indications. This presentation will address the cannabis plant, its cultivation/propagation, its chemistry and preparations derived from the plant on both licit and illicit markets. The widespread legalization of cannabis for medical and to a lesser extent recreational purposes by many states poses new challenges to both clinical and forensic laboratories. Analytical methods for the quantitation of cannabinoids will be discussed and the development of cannabis based therapeutics will be elaborated. |
Long Abstract
Cannabis is an annual, dioceous (occasionally monoecious) and wind pollinated plant. The plant has been reported to contain >500 different compounds, of which 120 are the cannabinoids. Delta-9-tetrahydrocannabinol (Delta-9-THC), the major biologically active compound and cannabidiol (CBD), a non-psychoactive cannabinoid are the most studied cannabinoids for various indications. This presentation will address the cannabis plant, its cultivation/propagation, its chemistry and preparations derived from the plant on both licit and illicit markets. The widespread legalization of cannabis for medical and to a lesser extent recreational purposes by many states poses new challenges to both clinical and forensic laboratories. Analytical methods for the quantitation of cannabinoids will be discussed and the development of cannabis based therapeutics will be elaborated.
References & Acknowledgements:
Not Applicable
| Description | Y/N | Source |
| Grants | no | |
| Salary | no | |
| Board Member | no | |
| Stock | no | |
| Expenses | no |
IP Royalty: no
| Planning to mention or discuss specific products or technology of the company(ies) listed above: | no |